Mechanisms of Action of Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia. [electronic resource]
- Antimicrobial agents and chemotherapy 10 2017
Publication Type: Journal Article
1098-6596
10.1128/AAC.01226-17 doi
Animals Anti-Bacterial Agents--therapeutic use Antimicrobial Cationic Peptides--biosynthesis Autophagy-Related Protein 5--biosynthesis Beclin-1--biosynthesis Drug Synergism Female Glutamate-Cysteine Ligase--biosynthesis Glutathione Reductase--biosynthesis Humans Interferon-gamma--biosynthesis Interleukin-6--biosynthesis Macrophages, Alveolar--immunology Mice Mice, Inbred C57BL Nitric Oxide Synthase Type II--biosynthesis Pneumocystis--drug effects Pneumonia, Pneumocystis--drug therapy Primaquine--therapeutic use Trimethoprim, Sulfamethoxazole Drug Combination--therapeutic use Tumor Necrosis Factor-alpha--biosynthesis Vitamin D--therapeutic use Cathelicidins